CompletedN/Aketamine
Ketamine Anesthesia in Electroconvulsive Therapy
Sponsored by Mayo Clinic
NCT ID
NCT01367119
Target Enrollment
38 participants
Start Date
2011-05
Est. Completion
2012-03
About This Study
Does the use of ketamine as the anesthetic medication in electroconvulsive therapy (ECT) accelerate the antidepressant effect of ECT? The study hypothesis was that depressed subjects receiving ECT with ketamine as the anesthetic agent would demonstrate a faster rate of improvement, defined as lower depression ratings after the second ECT than depressed patients receiving ECT with the usual anesthetic agent.
Conditions Studied
Interventions
- •Ketamine
- •methohexital
Eligibility
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion criteria: * Diagnosis of depression, either unipolar or bipolar * Subjects receiving ECT at the Mayo Clinic Exclusion criteria: * Subjects not giving their own consent to ECT * Subjects with schizophrenia, schizoaffective disorder, or dementia * Subjects diagnosed with a major neurological disorder such as epilepsy, Parkinson disease, multiple sclerosis, or a neurodegenerative dementia.
Study Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States